Pelvic tumors, sacral tumor
Conditions
Interventions
Partial abdominal aortic balloon occlusion:Partial abdominal aortic balloon occlusion
Complete abdominal aortic balloon occlusion :Complete abdominal aortic balloon occlusion
Sponsors
Peking University People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. In patients with sacral and pelvic tumors, such as chordoma, chondrosarcoma, giant cell tumor of bone, Ewing sarcoma, osteosarcoma or other malignant tumors, the preoperative examination showed that the blood supply of the tumor was abundant and the intraoperative bleeding was expected to be more; 2. Patients aged from 18 to 60, regardless of gender; 3. Patients who have no contraindications for abdominal aortic balloon implantation and need abdominal aortic balloon implantation; 4. Patients whose life expectancy is more than one year; 5. Patients with good compliance can cooperate with the whole process of treatment, evaluation and follow-up.
Exclusion criteria
Exclusion criteria: 1. Patients with other malignant tumors; 2. Patients with uncontrollable hypertension (systolic blood pressure >= 140mmHg or diastolic blood pressure >= 90mmHg, despite the best drug treatment); 3. According to NYHA criteria, patients with grade III - IV cardiac insufficiency, or patients with left ventricular ejection fraction less than 50% indicated by echocardiography, had myocardial infarction within 6 months before enrollment, heart failure of grade II or above of New York Heart Association, angina pectoris under control, pericardial disease with clinical significance, or acute ischemia or active conduction system abnormality indicated by ECG; 4. Patients with history of lower extremity or pelvic thrombosis or tumor thrombus, blood supply disorder of lower extremity or pelvic cavity, vascular malformation of lower extremity or pelvic cavity; 5. Those who have a history of psychotropic drug abuse and can not give up or have mental disorders; 6. Any situation that the researcher thinks may damage the subject or cause the subject unable to meet or carry out the research requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative blood loss; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time of occlusion; | — |
Countries
China
Contacts
Public ContactYan Taiqiang
Peking University People's Hospital
Outcome results
None listed